Home / Centerstage / 2005 / september / Week 1 /
In a deal between pharmaceuticals, Swiss based Novartis AG bid to buy American based Chiron Corp for $ 4.5 Billon is rejected by the board of Chiron.
Monday, 5 September, 2005